Catalyst Wire Dossier Catalyst Wire Dossier

Luspatercept

luspatercept
Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for Luspatercept, covering 2020-01-27 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions [Phase 3]

See pricing